PCI Pharma Services Opens New England Center of Excellence to Bring Global Clinical Supply Capabilities to New England
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the opening of its Clinical Services Center of Excellence in Bridgewater, MA, the first facility of its kind to support the growing needs of global developers of biologics in the New England region. The new facility will provide increased flexibility and scalability for secondary packaging, distribution and cold chain storage of innovative therapies in development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220825005234/en/
Rendering of the new PCI facility in Bridgewater, MA. (Photo: Business Wire)
“As the northeast biopharma market continues to grow, we are bringing distinctive clinical supply capabilities to the backyard of product development, creating a personalized and responsive approach to evolving client needs,” said Salim Haffar, CEO, PCI Pharma Services. “This newest facility follows our growth in facilities in Berlin, Germany, and Rockford, Illinois, and will create significant local job growth potential.”
To keep pace with the growth in biologics and gene therapies, which require cold chain infrastructure including deep freeze, the new facility has a capacity for a -20°C freezer, 35 ultra-low temperature freezers at -80°C and 12 liquid nitrogen freezers. The Center of Excellence also features a temperature-controlled room containing a 5,000 square foot cooler at 2° to 8°C, each with five levels of warehouse racking. A 1000-square-foot cold secondary packaging room will eventually be converted to primary packaging with the planned construction of an additional secondary packing unit.
“Boston is a booming biotech market with hundreds of local organizations developing new compounds in the biologics space,” said Craig LaMarca, General Manager of Boston Clinical Trial Services, PCI Pharma Services. “The facility features leading technologies and capabilities, making it a crucial component to help our clients deliver life-saving therapies to patients safely and efficiently.”
PCI currently occupies 50,000 square feet of the new 100,000 square foot building, with the remaining space available for lease. The campus was constructed to reflect Environmental Social Governance (ESG) and sustainability efforts. These features include a complex stormwater runoff system with a series of ponds that filter the water before it leaves the site, an underground oil and sedimentation separation tank, electric vehicle chargers and the exclusive use of LED lighting throughout the building.
The opening of the New England Center of Excellence marks the latest in a series of worldwide expansions for PCI including six sites across three continents, including Bedford, New Hampshire; Berlin, Germany; San Diego, California; Rockford, Illinois; and Melbourne, Australia. In February 2022, PCI sites in San Diego and Melbourne added innovative equipment with aseptic fill-finish capabilities to enhance PCI’s global offerings and deliver much-needed capacity to early-phase clinical clients.
For more information on PCI’s aseptic fill-finish and lyophilization capabilities, please click here.
About PCI Pharma Services
PCI is a leading global CDMO, providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 50 successful product launches each year and over five decades in the healthcare services business. We currently have 30 sites across seven countries (Australia, Canada, U.S., Ireland, Wales, Germany and Spain) and over 4,300 employees that work to bring life-changing therapies to patients. Leading technology and continued investment enable us to address global drug development needs throughout the entire product life cycle – from manufacturing capabilities through the clinical trial supply chain and into commercialization. Our clients view us as an extension of their business and a collaborative partner with the shared goal of improving patients’ lives.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220825005234/en/
Contact information
Ty Guzman-Touchberry, WE Communications
tgtouchberry@we-worldwide.com / +1-212-551-4877
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Eaton Receives 2024 Automotive News PACEpilot Recognition for Its 4-Speed Electrified Vehicle Transmission6.5.2024 12:30:00 CEST | Press release
Intelligent power management company Eaton’s heavy-duty 4-speed electrified vehicle (EV) transmission was named a 2024 Automotive News PACEpilot Innovation to Watch at an awards ceremony on April 29. The recognition acknowledges post-pilot, pre-commercial innovations in the automotive and future mobility space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240506431002/en/ Members of Eaton’s heavy-duty 4-speed electrified vehicle (EV) transmission team are, left to right, Scott Adams, Julie Marshaus, Justin Hopkins and Mark Kramer. (Photo: Business Wire) Eaton’s EV transmission provides superior performance on grades and acceleration for electric commercial vehicles while offering more flexible gear ratios compared to competitive technologies. The compact 4-speed transmission for heavy-duty applications is designed to improve system efficiency, enabling longer vehicle range and battery life. “We are honored to be chosen by
Ex- DocuSign, Oracle Leader Appointed to 6sense Senior Vice President of GTM International6.5.2024 10:00:00 CEST | Press release
6sense®, the leading platform to revolutionize the way B2B organizations create, manage, and convert pipeline to revenue, today announced the recent appointment of Andy Champion as Senior Vice President of GTM International. Champion’s impressive background brings over three decades of highly relevant experience to the organization which includes sales and marketing expertise at high growth, globally focused, private and public companies. “Andy’s track record of scaling organizations, both in headcount and revenue, will be instrumental in our global growth plans,” said Mark Ebert, SVP of Sales at 6sense. "But he also carries with him a unique ability to foster and develop both a fun and high-performing team culture. With a new London office space opening soon, I am incredibly excited for this next chapter for 6sense." The announcement highlights 6sense’s growing influence in the B2B sales and marketing landscape, with continued expansion efforts into new geographies and verticals servi
Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site6.5.2024 09:00:00 CEST | Press release
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility. This new line will be capable of handling both HFA-152a and HFO-1234ze propellants — that have a GWP of 90% and 99.9% lower than the industry standard HFA-134a, respectively — and is anticipated to be operational in 2026. Kindeva’s first pMDI manufacturing line, which was announced in 2022, is in its installation phase and will be completed later in 2024. Milton Boyer, Kindeva’s CEO said: “This investment will bring to the market one of the first large-volume commercial green propellant lines to the contract manufacturing market capable of supplying up to 50 million pMDI units per year. This second investment in low-GWP GMP manufacturing capacity further underscores Kindeva’s c
INRED and SES to Provide High-Throughput Connectivity Across Colombia’s Amazonas6.5.2024 08:50:00 CEST | Press release
Following a series of successful collaborations to close the digital divide, Colombian local connectivity service provider INRED and SES will deliver high-throughput connectivity services via SES’s Medium Earth Orbit (MEO) satellites to more than 500 homes, schools, government entities, and thousands of habitants in the department of Amazonas, both companies announced today. With the aim of supporting the Colombian government’s efforts to connect remote and hard-to-reach locations under the Amazonas Digital initiative, INRED is leveraging SES’s MEO satellites to connect the city of Leticia and other rural areas in Amazonas. SES’s MEO satellites, which orbit at 8,000 km above the Earth’s surface, will play a major role in complementing the government’s digital inclusion initiatives to deliver connectivity to even the most hard-to-reach regions in the country, ensuring people and businesses in these areas have equal access to social and economic opportunities. “Having a long-term partner
Xylem Unveils 'Reuse Brew'6.5.2024 08:00:00 CEST | Press release
In an innovative move to tackle Europe's escalating water scarcity, global water technology leader Xylem (NYSE: XYL), today announced the launch of Reuse Brew. This unique Bavarian beer, crafted from high-quality treated wastewater, marks a significant advancement in water recycling technologies and offers a sustainable solution to the increasing challenges posed by climate change. The development of Reuse Brew is the culmination of a partnership between the Chair of Brewery and Beverage Technology at Technical University of Munich (TUM), the Chair of Urban Water Systems Engineering at TUM, the city of Weissenburg in Bavaria, and Xylem. This collaboration showcases the transformative potential of advanced water treatment technologies in producing a palatable beer, promoting sustainable water management practices across Europe. "Reuse Brew is not merely an exceptional beer; it exemplifies the vast capabilities of water recycling in combating the pressing issue of water scarcity," said R